{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Johnson & Johnson", "item": "https://www.patentleaderboard.com/2021/company/jnj"}, {"@type": "ListItem", "position": 4, "name": "David A. Kummer", "item": "https://www.patentleaderboard.com/2021/inventor/fl:da_ln:kummer-4"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DK

David A. Kummer — 3 Patents in 2021

Johnson & Johnson: 3 patents #144 of 1,204Top 15%
San Diego, CA: #626 of 4,495 inventorsTop 15%
California: #8,414 of 66,859 inventorsTop 15%
Overall (2021): #86,092 of 548,734Top 20%
3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10975037 Phenyl substituted pyrazoles as modulators of RORγt Steven Goldberg, Connor L. Martin, Elizabeth G. Fennema, Rachel Nishimura, Craig R. Woods +4 more 2021-04-13 $63,321,000
10975057 6-aminopyridin-3-yl pyrazoles as modulators of RORgT Steven Goldberg, Connor L. Martin, Elizabeth G. Fennema, Rachel Nishimura, Anne Fourie +1 more 2021-04-13 $63,321,000
10947252 Inhibitors of KEAP1-Nrf2 protein-protein interaction J. Kent Barbay, Wenying Chai, Gavin Hirst, Kevin D. Kreutter, Kelly J. McClure +5 more 2021-03-16 $128,294,000